Trial Profile
Safety, tolerability, pharmacokinetics and pharmacodynamics of co-administration of mirogabalin and zolpidem in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Mirogabalin (Primary) ; Zolpidem (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 03 Jun 2016 New trial record
- 14 May 2016 Results presented at the 35th Annual Scientific Meeting of the American Pain Society